About the Conference:
Advances in molecular high-throughput assays for gene expression (DNA/RNA) signatures have generated the parallel need for well annotated properly preserved biospecimens. Samples from both diseased and unaffected normal tissues are often required. Like traditional banks, biobanks are meant to be used and are most useful when the needs of end-users (researchers) are considered. Thus, a well managed biobank is a critical prerequisite for high-quality biological research. Cambridge Healthtech Institute’s Inaugural The Science of Biobanking is uniquely designed to explore the critical interactions between bioDEPOSITORS, bioBANKERS, and bioRECIPENTS who are all invested in the future of bioMOLECULAR research.

Session Topics Including:

• Comprehensive BioBanking: The Specimen Life Cycle
• Defining and Utilizing Biospecimens with an Eye for Fit-for-Purpose
• Profiling Gene Expression from Tissue

Presentation Titles and Distinguished Speakers Included on the DVD:

The Biospecimen is the Center of the Molecular Medicine Universe

Carolyn Compton, M.D., Ph.D., Director, Biorepositories and Biospecimen Research, National Cancer Institute

Challenge of Safeguarding Diagnostic Properties of Tissue Sample While Securing Sufficient Sample for Biopreservation

Renata B. Greenspan, COL. MC (Ret), Director, BioSpecimen Network; Associate Director, U.S. Military Cancer Institute, Walter Reed Army Medical Center

Impacts of Biopreservation on Disparities Between Biospecimens and Their Origins

Aby J. Mathew, Ph.D., Senior Scientist & Senior Director, Strategic Relations, BioLife Soutions, Inc.

Biological Samples – Unlock the Potential

Diane Leong, Ph.D., Associate Director, Sample Repository, Genentech

Managing Large Biorepository Collections for Collaborative Translational Research

Johanna L. Goderre, B.A., Assistant Project Director, Epidemiology, Johns Hopkins Bloomberg School of Public Health

The Four Pillars of Good Biorepository Management

Jonathan Horan, B. Sc. / Product Manager, Vitro Ltd.

Increasing DNA Extraction Capacity – A Technology Overview

Robert Corr, Ph.D., Associate Director, DNA & Biofluids Center, Pfizer Global Research & Development

Science-Guided Biobanking for Cancer Drug and Biomarker Development

Hartmut Juhl, M.D., Ph.D., CEO of Indivumed GmbH and Inostics GmbH, Adjunct Professor, Georgetown University, Adjunct Professor, University of Hamburg, Indivumed GmbH

Use of Specimens for Clinical Trials

Leonardo Sahelijo, M.D., Medical Director, Pharmacogenomics, Takeda Global R&D

FDA & Biospecimens: Panning for Gold Among the Rocks

Elizabeth Mansfield, Ph.D., Director, Personalized Medicine Staff, Office of In Vitro Diagnostic Devices, CDRH/FDA 

Defining Biospecimen Quality Within the Fit-for-Purpose Paradigm

Stephen M. Hewitt, M.D., Ph.D., Chief, Tissue Array Research Program and Applied Molecular Pathology Laboratory, National Cancer Institute, NIH

Living Tissue Banks: The Road to Personalizing Treatments for Brain Tumors

Santosh Kesari, M.D., Ph.D., Assistant Professor, Neurosciences, University of California San Diego

Bridging the Gap Between Biospecimen Procurer and User

Allison Hubel, Ph.D., Professor, Mechanical Engineering, University of Minnesota